Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1888.07m
AMGNAmgen, Inc. -2.40%197.881.3%$881.73m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$848.08m
BIIBBiogen, Inc. -7.14%293.781.5%$704.97m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$557.47m
MRNAModerna, Inc. -0.94%29.670.0%$530.64m
ILMNIllumina, Inc. -6.13%256.393.5%$443.31m
ALXNAlexion Pharmaceuticals, Inc. 0.18%89.952.0%$286.55m
AAgilent Technologies, Inc. -3.70%68.971.6%$220.14m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$187.28m
INCYIncyte Corp. 1.30%74.182.5%$178.88m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$164.58m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$163.42m
NVAXNovavax, Inc. 3.31%14.03114.7%$128.96m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$98.37m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.